Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 138.09 0.82 0.60% 10.05%
Accelerate Diagnostics 3.95 0.10 2.47% -69.52%
Becton, Dickinson and Co. 259.96 -4.67 -1.76% -0.11%
Bio-Rad Laboratories 582.91 -3.55 -0.61% -0.92%
Biocept 2.97 -0.05 -1.66% -54.66%
Bruker 67.61 1.14 1.72% 12.50%
Quest Diagnostics 138.45 0.59 0.43% 10.79%
Danaher 276.86 -3.59 -1.28% 16.25%
Exact Sciences 74.66 0.63 0.85% -51.50%
Fluidigm 2.98 0.14 4.93% -55.98%
GenMark Diagnostics 24.04 0 0% 169.66%
Hologic 70.89 0.26 0.37% -7.14%
Illumina 364.96 -4.54 -1.24% -13.31%
J&J 163.51 -1.36 -0.82% -1.49%
Luminex 36.99 0 0% 10.02%
Mettler Toledo International 1,462.64 5.77 0.40% 18.58%
Myriad Genetics 26.86 0.33 1.24% 1.17%
NanoString Technologies 34.95 2.36 7.24% -54.63%
OraSure Technologies 8.74 -0.08 -0.85% -39.22%
Oxford Immunotec Global 21.95 -0.04 -0.18% 80.07%
Pacific Biosciences Of California 10.67 0.59 5.87% -70.32%
PerkinElmer 174.28 -0.50 -0.29% 15.38%
Quidel 102.61 -2.41 -2.30% -56.98%
Repligen 189.79 6.04 3.28% -11.84%
Thermo Fisher Scientific 575.80 -4.53 -0.78% 10.98%
Veracyte 28.92 1.82 6.75% -47.78%
Waters 322.94 4.39 1.38% 18.14%

Indexes Price Day Year
NASDAQ 13855 86.21 0.63% 1.61%

Myriad Genetics
Myriad Genetics, Inc. (Myriad) is a genetic testing and precision medicine company. Myriad is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. It operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is designed to determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can progress patient care. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services, such as finance, human resources, legal and information technology. The Company's products include myRisk, BRACAnalysis, BRACAnalysis CDx myChoice CDx, Prolaris, EndoPredict, Foresight and Prequel.